From: ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome
 | Health Group (n=60) | PNS (n=196) | Z/x2 | P |
---|---|---|---|---|
Male /female | 30/30 | 124/72 | 1.79 | 0.18 |
Ages (years) | 31.5(29.37-42.83) | 32(32.88-37.75) | -0.37 | 0.71 |
CHO (mmol/L) | 3.88(3.26-4.13) | 6.53(6.53-7.50) | -5.58 | <0.001 |
TG (mmol/L) | 0.95(0.83-1.25) | 2.05(2.18-2.69) | -5.34 | <0.001 |
LDL (mmol/L) | 1.96(1.69-2.15) | 3.96(4.10-4.85) | -5.97 | <0.001 |
HDL (mmol/L) | 1.22(1.03-1.32) | 1.65(1.77-2.06) | -4.36 | <0.001 |
24hUP(g/d) | 0.09(0.08-1.00) | 1.75(2.26-3.98) | -5.27 | <0.001 |
ALB(g/L) | 45.4(41.01-46.69) | 31.05(30.05-33.15) | -5.21 | <0.001 |
Scr(umol/L) | 55.2(41.81-58.41) | 72.45(74.53-94.07) | -3.93 | <0.001 |
BUN(mmol/L) | 5.45(4.61-6.08) | 6.36(4.66-14.22) | -2.12 | 0.34 |
Serum ANGPTL3(ng/ml) | 32(26.35-39.66) | 70.44(63.95-76.51) | -4.81 | <0.001 |